{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:52:01Z","timestamp":1777870321039,"version":"3.51.4"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-02076-6","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T12:01:45Z","timestamp":1725192105000},"page":"2551-2559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Timing of relapse as a key indicator of steroid-sparing requirements in childhood idiopathic nephrotic syndrome"],"prefix":"10.1093","volume":"37","author":[{"given":"Khairunnisa","family":"Mohamad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadzliana","family":"Zainal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur Arzuar","family":"Abdul Rahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengku Hasnita","family":"Tengku Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,9,1]]},"reference":[{"key":"2076_CR1","doi-asserted-by":"publisher","first-page":"2020030494","DOI":"10.1542\/2020-029249","volume":"148","author":"F Veltkamp","year":"2021","unstructured":"Veltkamp F, Rensma LR, Bouts AHM (2021) Incidence and relapse of idiopathic nephrotic syndrome: meta-analysis. Pediatrics 148:2020030494. https:\/\/doi.org\/10.1542\/2020-029249","journal-title":"Pediatrics"},{"key":"2076_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ekir.2019.12.015","volume":"5","author":"SA Carter","year":"2020","unstructured":"Carter SA, Mistry S, Fitzpatrick J, Banh T, Hebert D, Langlois V, Pearl RJ, Chanchlani R, Licht CPB, Radhakrishnan S, Brooke J, Reddon M, Levin L, Aitken-Menezes K, Noone D, Parekh RS (2020) Prediction of short- and long-term outcomes in childhood nephrotic syndrome. Kidney Int Rep 5:426\u2013434. https:\/\/doi.org\/10.1016\/j.ekir.2019.12.015","journal-title":"Kidney Int Rep"},{"key":"2076_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s13312-012-0220-4","volume":"49","author":"A Sinha","year":"2012","unstructured":"Sinha A, Hari P, Sharma K, Gulati A, Kalaivani M, Mantan M, Kumar Dinda A, Srivastava RN, Bagga A (2012) Disease course in steroid sensitive nephrotic syndrome. Indian Pediatr 49:881\u2013887","journal-title":"Indian Pediatr"},{"key":"2076_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170259","author":"F Aljebab","year":"2017","unstructured":"Aljebab F, Choonara I, Conroy S (2017) Systematic review of the toxicity of long- course oral corticosteroids in children. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0170259","journal-title":"PLoS One"},{"key":"2076_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00467-018-4119-8","volume":"34","author":"T Korsgaard","year":"2019","unstructured":"Korsgaard T, Andersen RF, Joshi S, Hagstr\u00f8m S, Rittig S (2019) Childhood onset steroid-sensitive nephrotic syndrome continues into adulthood. Pediatr Nephrol 34:641\u2013648. https:\/\/doi.org\/10.1007\/s00467-018-4119-8","journal-title":"Pediatr Nephrol"},{"key":"2076_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jpeds.2005.03.050","volume":"147","author":"EM R\u00fcth","year":"2005","unstructured":"R\u00fcth EM, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ (2005) Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr 147:202\u2013207. https:\/\/doi.org\/10.1016\/j.jpeds.2005.03.050","journal-title":"J Pediatr"},{"key":"2076_CR7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","volume":"38","author":"International Pediatric Nephrology Association","year":"2023","unstructured":"International Pediatric Nephrology Association (2023) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 38:877\u2013919. https:\/\/doi.org\/10.1007\/s00467-022-05739-3","journal-title":"Pediatr Nephrol"},{"key":"2076_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/14651858.CD002290.pub5","volume":"2020","author":"NG Larkins","year":"2020","unstructured":"Larkins NG, Liu ID, Willis NS, Craig JC, Hodson EM (2020) Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. Cochrane Database Syst Rev 2020:4. https:\/\/doi.org\/10.1002\/14651858.CD002290.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"2076_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5152\/TurkPediatriArs.2018.5749","volume":"53","author":"B Dakshayani","year":"2018","unstructured":"Dakshayani B, Lakshmanna M, Premalatha R (2018) Predictors of frequent relapsing and steroid-dependent nephrotic syndrome in children. Turk Pediatri Ars 53:24\u201330. https:\/\/doi.org\/10.5152\/TurkPediatriArs.2018.5749","journal-title":"Turk Pediatri Ars"},{"key":"2076_CR10","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00467-010-1537-7","volume":"25","author":"RF Andersen","year":"2010","unstructured":"Andersen RF, Thrane N, Noergaard K, Rytter L, Jespersen B, Rittig S (2010) Early age at debut is a predictor of steroid-dependent and frequent relapsing nephrotic syndrome. Pediatr Nephrol 25:1299\u20131304. https:\/\/doi.org\/10.1007\/s00467-010-1537-7","journal-title":"Pediatr Nephrol"},{"key":"2076_CR11","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s004670100024","volume":"16","author":"HK Yap","year":"2001","unstructured":"Yap HK, Han EJS, Heng CK, Gong WK (2001) Risk factor of steroid dependency in children with idiopathic nephrotic syndrome. Pediatr Nephrol 16:1049\u20131052","journal-title":"Pediatr Nephrol"},{"key":"2076_CR12","doi-asserted-by":"publisher","unstructured":"Situmorang D, Sekarwana N, Fadlyana E (2016) Risk factors of frequent relapse in pediatric nephrotic syndrome. Am J Biomed Res 4:10\u201312. https:\/\/doi.org\/10.12691\/ajmbr-4-1-3","DOI":"10.12691\/ajmbr-4-1-3"},{"key":"2076_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00467-012-2365-8","volume":"28","author":"J Harambat","year":"2013","unstructured":"Harambat J, Godron A, Ernould S, Rigothier C, Llanas B, Leroy S (2013) Prediction of steroid-sparing agent use in childhood idiopathic nephrotic syndrome. Pediatr Nephrol 28:631\u2013638. https:\/\/doi.org\/10.1007\/s00467-012-2365-8","journal-title":"Pediatr Nephrol"},{"key":"2076_CR14","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s00467-008-0914-y","volume":"23","author":"B Letavernier","year":"2008","unstructured":"Letavernier B, Letavernier E, Leroy S, Baudet-Bonneville V, Bensman A, Ulinski T (2008) Prediction of high-degree steroid dependency in pediatric idiopathic nephrotic syndrome. Pediatr Nephrol 23:2221\u20132226. https:\/\/doi.org\/10.1007\/s00467-008-0914-y","journal-title":"Pediatr Nephrol"},{"key":"2076_CR15","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00467-013-2736-9","volume":"29","author":"P Sureshkumar","year":"2014","unstructured":"Sureshkumar P, Hodson EM, Willis NS, Barzi F, Craig JC (2014) Predictors of remission and relapse in idiopathic nephrotic syndrome: a prospective cohort study. Pediatr Nephrol 29:1039\u20131046. https:\/\/doi.org\/10.1007\/s00467-013-2736-9","journal-title":"Pediatr Nephrol"},{"key":"2076_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jpeds.2009.12.020","volume":"156","author":"M Vivarelli","year":"2010","unstructured":"Vivarelli M, Moscaritolo E, Tsalkidis A, Massella L, Emma F (2010) Time for initial response to steroids is a major prognostic factor in idiopathic nephrotic syndrome. J Pediatr 156:965\u2013971. https:\/\/doi.org\/10.1016\/j.jpeds.2009.12.020","journal-title":"J Pediatr"},{"key":"2076_CR17","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2215\/CJN.09010912","volume":"8","author":"K Nakanishi","year":"2013","unstructured":"Nakanishi K, Iijima K, Ishikura K, Hataya H, Nakazato H, Sasaki S, Honda M, Yoshikawa N (2013) Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome. Clin J Am Soc Nephrol 8:756\u2013762. https:\/\/doi.org\/10.2215\/CJN.09010912","journal-title":"Clin J Am Soc Nephrol"},{"key":"2076_CR18","unstructured":"Hj Muhammad Ismail HI, Mohd Ibrahim H, Ng HP, Thomas T (2019) Paediatric Protocols for Malaysian Hospitals, 4th Edition. Kementerian Kesihatan Malaysia"},{"key":"2076_CR19","unstructured":"Hj Muhammad Ismail HI, Ng HK, Thomas T (2012) Paediatric protocols for malaysian hospitals, 3rd Edition. Kementerian Kesihatan Malaysia"},{"key":"2076_CR20","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00467-022-05693-0","volume":"38","author":"J Bharati","year":"2023","unstructured":"Bharati J, Tiewsoh K, Dawman L, Singh T, Gorsi U, Rajarajen AP, Sharma A, Chanchlani R, Ramachandran R, Harbir KS (2023) Long-term complications in patients with childhood-onset nephrotic syndrome. Pediatr Nephrol 38:1107\u20131113","journal-title":"Pediatr Nephrol"},{"key":"2076_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1053\/ajkd.2003.50116","volume":"41","author":"F Fakhouri","year":"2003","unstructured":"Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Gr\u00fcnfeld JP, Niaudet P (2003) Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis 41:550\u2013557. https:\/\/doi.org\/10.1053\/ajkd.2003.50116","journal-title":"Am J Kidney Dis"},{"key":"2076_CR22","doi-asserted-by":"publisher","unstructured":"Abeyagunawardena S, De Silva ESK, Abeyagunawardena AS (2021) Levamisole and mycophenolate mofetil significantly reduce the relapses following cyclosporine a withdrawal in steroid dependent nephrotic syndrome. Arch Nephrol Urol. https:\/\/doi.org\/10.26502\/anu.2644-2833035","DOI":"10.26502\/anu.2644-2833035"},{"key":"2076_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4038\/sljch.v46i4.8377","volume":"46","author":"S Abeyagunawardena","year":"2017","unstructured":"Abeyagunawardena S, Jayaweera AHHM, Thalgahagoda RS, Karunadasa UI, Abeyagunawardena AS (2017) Intravenous pulsed vs oral cyclophosphamide therapy in steroid dependent nephrotic syndrome. Sri Lanka J Child Health 46:317. https:\/\/doi.org\/10.4038\/sljch.v46i4.8377","journal-title":"Sri Lanka J Child Health"},{"key":"2076_CR24","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/ki.2008.24","volume":"73","author":"K Ishikura","year":"2008","unstructured":"Ishikura K, Ikeda M, Hattori S, Yoshikawa N, Sasaki S, Iijima K, Nakanishi K, Yata N, Honda M (2008) Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial. Kidney Int 73:1167\u20131173. https:\/\/doi.org\/10.1038\/ki.2008.24","journal-title":"Kidney Int"},{"key":"2076_CR25","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.kint.2017.08.011","volume":"93","author":"MP Gruppen","year":"2018","unstructured":"Gruppen MP, Bouts AH, Jansen-van der Weide MC, Merkus MP, Zurowska A, Maternik M, Massella L, Emma F, Niaudet P, Cornelissen EAM, Schurmans T, Raes A, van de Walle J, van Dyck M, Gulati A, Bagga A, Davin JC (2018) A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome. Kidney Int 93:510\u2013518. https:\/\/doi.org\/10.1016\/j.kint.2017.08.011","journal-title":"Kidney Int"},{"key":"2076_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/ijp.ijp_673_21","volume":"55","author":"GC Bhatt","year":"2023","unstructured":"Bhatt GC, Patel B, Das RR, Malik S, Bitzan M, Mishra NR (2023) Efficacy and safety of levamisole in childhood nephrotic syndrome: a meta-analysis. Indian J Pharmacol 55:43\u201352. https:\/\/doi.org\/10.4103\/ijp.ijp_673_21","journal-title":"Indian J Pharmacol"},{"key":"2076_CR27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.kint.2018.08.039","volume":"95","author":"A Sinha","year":"2019","unstructured":"Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A (2019) Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial. Kidney Int 95:210\u2013218. https:\/\/doi.org\/10.1016\/j.kint.2018.08.039","journal-title":"Kidney Int"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02076-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-02076-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02076-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:12Z","timestamp":1777564392000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/9\/2551\/8306177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2076"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-02076-6","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,1]]},"assertion":[{"value":"25 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study received ethical approval from Malaysia's Regulatory and Ethics Committees (Ref: 23\u201300815-NNF) and was conducted in compliance with the Declaration of Helsinki and the Malaysian Good Clinical Practice Guideline. Approval for publication has been obtained from the Director General of Health Malaysia.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All procedures involving human participants adhered to the required ethical standards, and no animal studies were involved.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was waived due to the retrospective nature of the study, and the analysis utilized anonymous clinical data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}